You are here

Lyxumia

FDA Staff Questions Usefulness of Sanofi’s Diabetes Drug Combo

Bloomberg

Mon, 05/23/16 - 10:16 am

clinical trials

Victoza tops Sanofi's Lyxumia in trial, adding to Novo's GLP-1 arsenal

Fierce Pharma

Wed, 09/16/15 - 06:01 pm

Sanofi's diabetes hopeful Lyxumia gets a raft of good safety grades

Fierce Pharma Marketing

Mon, 06/8/15 - 10:03 pm

Sanofi's diabetes franchise one step closer to U.S. Lyxumia launch

Fierce Pharma

Thu, 03/19/15 - 11:43 am

Can Once Daily GLP-1 Lyxumia Be The Next Major Growth Driver For Sanofi?

Seeking Alpha

Wed, 04/16/14 - 09:37 am

Sanofi's LixiLan Progresses

Yahoo/Zacks.com

Fri, 01/17/14 - 08:37 am

Sanofi's Lyxumia Gets Japanese Nod

Yahoo/Zacks

Wed, 07/3/13 - 11:11 am

Novo Nordisk shares hit by concerns over rival diabetes drugs

Reuters

Mon, 06/17/13 - 09:17 am

Sanofi's New Diabetes Play Moves Forward

Motley Fool

Tue, 02/5/13 - 10:30 am

Sanofi Wins EU Backing for Drugs Against Diabetes, Cancer

Bloomberg

Sat, 11/17/12 - 01:42 pm

colorectal cancer

Sanofi Wins EU Backing for New Drugs Against Diabetes and Cancer

Bloomberg

Fri, 11/16/12 - 10:43 am

colorectal cancer

Sanofi Defends Lyxumia Under Scrutiny at Diabetes Meeting

Bloomberg

Thu, 10/4/12 - 10:50 am

Bristol-Myers Squibb

Sanofi Singles Out Top Pipeline Prospects, New Cost Cuts

Motley Fool

Tue, 09/6/11 - 12:17 pm

Visamerin/Mulsevo

Positive Results for Investigational Compound Lyxumia (Lixisenatide) Presented at American Diabetes Association's 71st Annual Scientific Sessions

Yahoo/PR NewsWire

Sat, 06/25/11 - 08:43 pm

Sanofi's diabetes drug cuts blood sugar, weight-study

Reuters

Tue, 05/31/11 - 01:54 pm